Highlights and Quick Summary
- Net Income Growth for the quarter ending June 30, 2023 was 0.03 (a -130.3% decrease compared to previous quarter)
- Year-over-year quarterly Net Income Growth decreased by -95.75%
- Annual Net Income Growth for 2022 was 0.03 (a -100.04% decrease from previous year)
- Annual Net Income Growth for 2021 was -61.31 (a -6409.66% decrease from previous year)
- Annual Net Income Growth for 2020 was 0.97 (a 418.79% increase from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income Growth of DURECT Corporation
Most recent Net Income Growthof DRRX including historical data for past 10 years.Interactive Chart of Net Income Growth of DURECT Corporation
DURECT Corporation Net Income Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.03 | -0.11 | – | – | – |
| 2022 | -0.49 | 0.75 | -0.26 | -0.07 | 0.03 |
| 2021 | -2.61 | -0.07 | -1.64 | -0.02 | -61.31 |
| 2020 | 2.03 | -3.69 | 2.98 | -0.4 | 0.97 |
| 2019 | 0.42 | 0.27 | -0.03 | 0.14 | 0.19 |
| 2018 | -1.89 | -1.44 | 0.29 | -0.02 | -5.85 |
| 2017 | 1.93 | 1.69 | -0.1 | -0.03 | 0.89 |
| 2016 | -0.51 | -0.36 | -0.65 | -0.62 | -0.52 |
| 2015 | 0.02 | 0.09 | 0.0 | -0.35 | -0.03 |
| 2014 | -0.16 | -0.18 | -0.06 | 0.31 | -0.03 |
| 2013 | 0.07 | -0.25 | -0.19 | -1.17 | -2.32 |
| 2012 | -1.57 | 0.04 | – | – | 1.86 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic